首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 62 毫秒
1.
HSP70多肽刺激PBMCs体外扩增γδT细胞及其抗肿瘤效应的研究   总被引:6,自引:0,他引:6  
运用分离提纯所获的肿瘤膜蛋白HSP70-多肽在体外刺激人外周血单个核细胞(PBMCs),成功地建立了γδT细胞的扩增培养系统。扩增培养后γδT细胞从占外周血T淋巴细胞的3.5%±2.8%(健康人样本)、11.5%±10.8%(急性白血病样本)相应地升高至52.8%±7.9%和60.4%±5.9%,并以表达TCRVγ9-Vδ2亚型为主。运用51Cr细胞毒试验探讨了γδT细胞的杀伤效应,发现:HSP70-多肽激活的γδT细胞对一系列肿瘤细胞包括NK敏感的K562、LAK敏感的Daudi以及自体或异体新鲜肿瘤细胞等都具有高效的细胞毒活性,另外,在γδT细胞上清中可检出高水平的IFN-γ、IL-2、TNF、IL-8等细胞因子。以上结果提示:γδT细胞作为一种细胞毒性T淋巴细胞具有高效、特异的杀伤效应,在肿瘤免疫中具有重要作用。  相似文献   

2.
HSP患儿治疗前后血清sTNF—R水平变化及意义   总被引:6,自引:0,他引:6  
sTNF-R是细胞表面膜结合型肿瘤坏死因子受体(mTNF-R)经蛋白激酶等裂解而形成的。sTNF-R有两型:sTNF-RI和sTNF-RII。TNF包括TNF-α和TNF-β是一种具有多种生物学效应的炎性介质,其生物学活性通过与mTNF-R结合而介导1。为了探讨HSP患儿血清sTNF-R的水平变化及其意义,我们检测了过敏性紫癜HSP患儿治疗前后、有无并发肾炎HSP患儿及其中9例治疗后复发的急性期HSP患儿血清sTNF-R的水平。1材料和方法1.1材料研究对象:SHP患儿26例,其中…  相似文献   

3.
秋水仙碱对肿瘤坏死因子—α基因表达的影响   总被引:6,自引:0,他引:6  
微管聚合抑制剂秋水仙碱(Col,10μmol/L)可抑制LPS刺激PU5-1.8细胞的TNF-a基因表达,以前工作曾证实Col主要抑制TNF-αmRNA的转录。本研究进一步证实这种抑制作用呈延迟性,即Col需作用3小时才能充分表现其负性影响。而且这种抑制作用可被蛋白合成抑制剂放线菌酮(CHX)完全阻断。单用Col对LPS诱导的TNF-αmRNA稳定性无明显影响,而与CHX联用时则可明显延长LPS诱导的TNF-αmRNA半衰期。以上资料堤示,Col对TNF-α基因表达的影响可能是对其在转录及转录后水平综合影响的结果。  相似文献   

4.
使用抗CD3单抗诱导新鲜分离的人外周血单个核细胞(PBMC)凋亡,同时观察细胞因子对其影响,18h后电镜发现处理组发生典型凋亡改变,DNA电泳出现典型阶梯状条。TUNEL法流式细胞仪检测发现处理组凋亡发生率39.6%,显著高于对照组(P〈0.01),IFN-γ、TNF-α可显著增强抗CD3单抗诱导的凋亡,IL-1 ̄IL-3,TNF-α对凋亡无明显影响。CsA可抑制剂CD3单抗诱导的凋亡,但加入IF  相似文献   

5.
FasL与TNF引起凋亡的研究进展   总被引:6,自引:0,他引:6  
死亡分子与死亡分子受体相互作用引发的细胞凋亡在保持自身平稳发挥着无法代替的重要作用。目前FasL,TNF和TRA1三个死亡分子及FasTNFR,DR3/WS1-1和CAR1四个死亡分子受体已被确定,本文就FasL和TNF两个死亡分子在与其受体Fas下调免疫反应,效应分子和免疫特赦的研究现状予以综述。  相似文献   

6.
T淋巴细胞活化是一个涉及多种膜表面分子和受体以及一系列相关多肽的复杂过程,为了使T细胞发挥更好的识别和杀伤癌细胞的功能,采用抗CD3、CD28、CD80(B7.1)、CD2、CD58McAb分别刺激健康人PBLs后作用肝癌细胞,对作用前后PBLs用FACS进行表型分析,结果发现:作用后CD3和CD8分子表达比作用前明显增高,而CD4分子无显著变化,同时基因家族采用RT-PCR-Southern印迹  相似文献   

7.
羧甲基茯苓多糖对HPBL分泌IL—2,TNF,IL—6,IFN—γ的调节作用   总被引:16,自引:0,他引:16  
用CMP培养外周血淋巴细胞(HPBL)24、36、48、72h采样检测的IL-2、TNF、IL-6、IFN-γ效价分别可达13.6±4.3,41.9±2.0,1837.4±464.3,1037.9±211.0U/ml,分别比无CMP的细胞培养对照组的效价高0.8,7.4,0.5,10.9倍(P<0.01),说明CMP具有IL-2、TNF、IL-6、IFN-γ的诱生剂功能。由CMP预处理HPBL后经PHA和/或ConA促诱生组的IL-2、TNF、IL-6、IFN-γ效价分别比无CMP的PHA和/或ConA刺激的相应常规诱生组高1.2~2.8,0.5~1.1、0.5~0.8、0.4~0.6倍(P<0.01),尤以CMP+PHA+ConA促诱生细胞因子效果最佳(P<0.01),说明CMP又具有IL-2、TNF、IL-6、IFN-γ促诱生效应。  相似文献   

8.
CMP促诱生IL—2,TNF—α,IL—6,IFNγ/α效应和产品中试   总被引:3,自引:0,他引:3  
杨吉成 《免疫学杂志》1998,14(3):194-197
用羧甲基茯苓多糖(CMP)预处理人外周血淋巴细胞(HPBL),在以PHA和ConA为主的复合诱生剂诱导培养24、36、48、72h采样检测的促诱生组TNF-α、IL-2、IL-6、IFNγ效价(x±s)分别为456.1±24.2,475.6±185.7,7433±1189.9,5583.0±535.5IU/ml,分别比无CMP的常规诱生组效价高1.5,3.8,1.8,1.4倍;在以NDV-F病毒为诱生剂诱导培养22h采样,并经酸化和中性化后检测的IFN-α效价可达21274.2±5523.0IU/ml,比无CMP的常规诱生组高1.2倍,均有显著差异(P<0.01),说明CMP对上述五种细胞因子均有明显的促诱生效应。此外,还采用CMP促诱生技术,对TNF-α、IL-2、IL-6、IFNγ和IFN-α细胞因子进行了中试,提出了低成本、高效益的中试工艺路线,有待于在制备天然细胞因子的细胞工程中推广应用  相似文献   

9.
血小板活化因子(PAF)对免疫应答的影响日益被重视。本文观察了血小板活化因子(PAF)对Balb/c小鼠B淋巴细胞抗体生成能力的影响及对小鼠腹腔巨噬细胞(Mφ)产生肿瘤坏死因子(TNF)的影响。实验证明,PAF(浓度为7.3×10-10mol/L~3.65×10-12mol/L)能明显促使B细胞抗体生成能力上升和Mφ产生TNF能力上升。实验组小鼠的溶血空斑数均明显高于对照组(P<0.05),且实验组Mφ产生的TNF对细胞杀伤率明显高于对照组(P<0.05)。  相似文献   

10.
本文采用ELISA方法检测培养的人脐静脉内皮细胞(HUVEC)表面玻璃连接蛋白受体(VitronectinreceptorVnR即整合素家庭的α_vβ_3)的表达改变;用(51)Cr-标记血小板((51)Cr-platelete,(51)Cr-pL)检测HUvEc的粘附功能;Fura-2/Am负载EC,测定HUVEC胞内游离钙离子浓度([Ca(2+)]),观察了高糖、肿瘤坏死因子-α(Tumornecrosisfactor-α,TNF-α)对EC粘附功能的影响。结果表明:①高糖(30mmol/L)可明显促进EC与PL的粘附(CPM值:361±2l.93VS2l9.67±16.26,n=6P<0.01),抗β3亚单位单抗(β3McAb)可部分阻断EC与PL粘附。TNF-α(1000μ/m1)也有相同作用(CPM值:4l0.7±17.6VS219.67±16.261n=6P<0.01),β3McAb也部分阻断TNF-α诱导的EC-PL间的粘附。②不同浓度高糖和TNF-α不同时间可影响EC表面的α_vβ_3表达,并且在一定范围内有浓度和时间依赖性。③高糖和TNF-α可明显增加EC的[Ca(2+)]i,上述资料提示?  相似文献   

11.
12.
Properties of chemoreceptors of tongue of rat   总被引:14,自引:0,他引:14  
  相似文献   

13.
14.
15.
A further analysis of already published data supports the position that retardates of low ability level less frequently have retarded siblings, retarded parents, and parents low in occupational level than do retardates higher in ability level. The analysis supports the position that there are two types of retarded individuals, persons retarded as a result of gene or chromosomal anomalies, brain injury, etc., who more frequently occur in the lower-level retardate group, and persons whose retardation represents polygenic segregation, who more frequently occur in the higher-level group.  相似文献   

16.
17.
Modes of Inheritance of Errors of Refraction   总被引:5,自引:0,他引:5       下载免费PDF全文
Eighteen families in which both parents had refractions within the range of +4·0 D to −4·0 D and axial lengths seen in emmetropia (22·3-26·0 mm) showed coefficients of correlation of the order 0·5 indicative of polygenic inheritance. Such coefficients were seen for axial length (0·407) and for the cornea (0·487), but not for the lens (which is known to be yoked to the axial length). No such coefficients were seen in 19 families in which one of the parents had axial length outside the emmetropic range (nine families with long axes and 10 with short axes).

The pattern of polygenic inheritance for emmetropia (completely correlated optical components) and errors of refraction up to 4·0 D (inadequately correlated components: correlation ametropia) follows that seen in stature and other measurable characters. In contrast the high refractive errors with their abnormal axial lengths (component ametropia) are—like the extremes in stature—pathological anomalies with monofactorial inheritance.

  相似文献   

18.
19.
20.
Editorial note. This article is published as part of a discussion. Particular issues of the article are disputable. First of all, this concerns the so-called “folder” method of introduction of international standards for medical devices to domestic medical practice (i.e., by direct translation of the standards and their publication as standardizing documents). Nevertheless, at least one of the problems, the problem of coordination between domestic state standards for medical devices and international recommendations of ISO and IEC, is undoubtedly of topical importance. Advancement of new health service legislation which is to be approved by law-makers will definitely introduce corrections into the present situation. The Editorial Board of Meditsinskaya Tekhnika believes this article will lessen these problems and to be welcomed by readers.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号